Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
Social Development Research Group, University of Washington, Seattle, WA, USA.
Addict Behav. 2023 Aug;143:107711. doi: 10.1016/j.addbeh.2023.107711. Epub 2023 Mar 30.
Little is known about the prospective relationship between cannabis use and pain reliever misuse. This study examined associations of non-medical and medical cannabis use with onset of non-medical pain reliever misuse among young adults in Washington State (WA), where non-medical cannabis is legal.
Data were from a cohort-sequential study of adults 18-25 residing in WA. Four annual surveys were used from cohorts recruited in 2014, 2015, and 2016. Participants who had not reported non-medical pain reliever misuse at baseline were included in discrete time survival analyses (N = 4,236). Odds ratios (ORs) were estimated for new onset of non-medical pain reliever misuse in any given follow-up year over the course of three years according to baseline non-medical and medical cannabis use.
When included separately in models, non-medical and medical cannabis use at baseline were associated with increased risk of non-medical pain reliever misuse adjusting for demographic characteristics as well as past year cigarette use and alcohol use (non-medical OR = 5.27; 95 % CI: 3.28, 8.48; medical OR = 2.21; 95 % CI: 1.39, 3.52). Including both forms of use in the model, associations of non-medical and medical cannabis use with non-medical pain reliever misuse onset remained (non-medical OR = 4.64; 95 % CI: 2.88, 7.49; medical OR = 1.65; 95 % CI: 1.04, 2.62).
Despite claims that cannabis use may reduce opioid use and related harms, findings suggest that cannabis use, including medical use, may not be protective, but instead may increase risk for non-medical pain reliever misuse.
对于大麻使用与止痛药滥用之间的前瞻性关系,人们知之甚少。本研究在美国华盛顿州(WA),研究了非医用和医用大麻使用与年轻人非医用止痛药滥用发作之间的关联,在该州,非医用大麻是合法的。
数据来自一项针对居住在 WA 的成年人 18-25 岁的队列序贯研究。使用了 2014 年、2015 年和 2016 年招募的队列的四次年度调查。在基线时未报告非医用止痛药滥用的参与者被纳入离散时间生存分析(N=4236)。根据基线非医用和医用大麻使用情况,在三年的随访过程中,在任何给定的随访年内,新出现非医用止痛药滥用的几率比(ORs)被估计。
当分别纳入模型时,基线时的非医用和医用大麻使用与非医用止痛药滥用的风险增加有关,调整了人口统计学特征以及过去一年的吸烟和饮酒情况(非医用 OR=5.27;95%CI:3.28,8.48;医用 OR=2.21;95%CI:1.39,3.52)。在模型中同时包含这两种形式的使用,非医用和医用大麻使用与非医用止痛药滥用发作的关联仍然存在(非医用 OR=4.64;95%CI:2.88,7.49;医用 OR=1.65;95%CI:1.04,2.62)。
尽管有说法称大麻使用可能会减少阿片类药物使用和相关危害,但研究结果表明,大麻使用,包括医用大麻使用,可能无法提供保护,反而可能增加非医用止痛药滥用的风险。